Table 6 Comparison of two groups of phosphate binders’ interventions
From: Routine laboratory testing in hemodialysis: how frequently is it needed?
|  | With ≤ 1 interventions per year for phosphate binders n = 133 | With > 1 interventions per year for phosphate binders n = 77 | P-value |
|---|---|---|---|
Age, median (IQR) | 72 (62, 80) | 70 (62, 77) | 0.284* |
Sex, M/F (%) | 86/47 (64.7/35.3) | 45/32 (58.4/41.6) | 0.370** |
Dialysis vintage (months), median (IQR) | 38 (25, 67) | 31 (17.5, 53.5) | 0.031* |
Diabetes, n(%) | 59 (44.4) | 40 (51.9) | 0.289** |
Hypertension, n(%) | 125 (94.9) | 76 (98.7) | 0.159*** |
Smoking status, n(%) | 43 (32.3) | 37 (48.1) | 0.024** |
CAD, n(%) | 57 (42.9) | 25 (32.9) | 0.156** |
Cancer, n(%) | 17 (12.8) | 11 (14.3) | 0.757** |
Yearly number of interventions in alfacalcidol prescription, median (IQR) | 0 (0, 1) | 0 (0, 2) | 0.021* |
Hemoglobin over one year, median (IQR) | 11.1 (10.6, 11.7) | 11.4 (10.9, 11.8) | 0.021* |
PTH over one year, median (IQR) | 211.6 (97.5, 374.9) | 278.0 (174.5, 463.2) | 0.007* |
Serum calcium over one year, Mean ± SD | 9.02 ± 0.43 | 8.99 ± 0.57 | 0.811**** |
Serum phosphate over one year, Mean ± SD | 4.29 ± 1.13 | 4.59 ± 0.95 | 0.045**** |
URR over one year, Mean ± SD | 0.76 ± 0.05 | 0.75 ± 0.05 | 0.099**** |